The follow-up of a Phase II trial of trastuzumab and bevacizumab for first-line metastatic or locally relapsed breast cancer is ongoing. [35] Phase III trials studying bevacizumab in combination ...

However, Roche faced a CHF 1bn sales decline from the loss of exclusivity on older products, including cancer therapies ...

Celltrions Vegzelma becomes Europes top prescribed anticancer drug in two years Celltrions cancer treatment Vegzelma achieves impressive market dominance in Europe within two years ...

Dose-dense AC every 2 weeks (four-times)then dose-dense ABI-007 260 mg/m 2 every 2 weeks (four-times) plus Bevacizumab (10 ... including in combination with trastuzumab, which is in ongoing ...

Tambe said the company, a subsidiary of the Bengaluru-based Biocon Ltd, has five products in the pipeline for launch in the ...

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, ...